Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Dermoscopy can help diagnose tuberous sclerosis by identifying unique skin patterns.

A 3-year-old boy was diagnosed with a rare, non-scarring hair loss condition called temporal triangular alopecia.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Moderate facial angiofibroma significantly reduces quality of life compared to almost-clear cases, highlighting the benefits of treatment.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

An 11-year-old girl with Trichotillomania developed a large hairball in her stomach, treated with medication, therapy, and family education.

The document's conclusion cannot be provided because the document is not accessible or understandable.

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

The boy's genetic diagnosis of ectodermal dysplasia helped improve management and counseling for him and his sister.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

The study found that Tourette Syndrome may be linked to certain immune system processes and synaptic signaling.

TCM is an effective and safe treatment for primary cicatricial alopecias.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Direct-to-consumer teledermatology is not effectively reaching underserved populations due to language, technology, and insurance barriers.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.